AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...
Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
South Korea food labels, Indonesia GM food hoaxes, China food safety concerns and more feature in this edition of Safety First.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results